Delphine Hequet

6PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 06, 2023
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.

D Hequet, N Hajjaji, E Charafe-Jauffret

|Apr 09, 2022
Variation over time of the factors influencing return to work and work capacities after a diagnosis of breast cancer: a study on the behalf of the Seintinelles research network.

Delphine Hequet, Anne-Sophie Hamy, Noemie Girard

|Apr 16, 2021
Prosigna test in breast cancer: real-life experience.

D Hequet, G Harrissart, D Krief

|Jul 11, 2019
Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study.

Delphine Héquet, Cyrille Huchon, Anne-Laure Soilly

|Aug 24, 2018
Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study.

Amélie Cariou, Roman Rouzier, Sandrine Baffert

|Oct 19, 2017
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers.

Delphine Hequet, Céline Callens, David Gentien

Pageof 1

Frequent Collaborators

1 joint publications

E Deluche